C07C 57/13
Dicarboxylic acids
C07C57/13 (Dicarboxylic acids) appears on 432 US grants and 548 published applications in this corpus.
Search patents in C07C- Granted patents
- 432
- Published applications
- 548
- Assignees
- 379
- Inventors
- 1,666
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 7 | 0 |
| 1979 | 7 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 5 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 1 |
| 2004 | 2 | 6 |
| 2005 | 1 | 2 |
| 2006 | 0 | 7 |
| 2007 | 4 | 6 |
| 2008 | 2 | 7 |
| 2009 | 2 | 4 |
| 2010 | 5 | 13 |
| 2011 | 11 | 16 |
| 2012 | 7 | 20 |
| 2013 | 14 | 27 |
| 2014 | 18 | 27 |
| 2015 | 21 | 23 |
| 2016 | 20 | 37 |
| 2017 | 30 | 29 |
| 2018 | 25 | 37 |
| 2019 | 30 | 25 |
| 2020 | 20 | 28 |
| 2021 | 17 | 23 |
| 2022 | 15 | 26 |
| 2023 | 11 | 46 |
| 2024 | 21 | 54 |
| 2025 | 25 | 50 |
| 2026 | 25 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases25 Aug 2026US 12,715,861 B2Beijing Grand Johamu Pharmaceutical Company, Ltd.
- Methods for the preparation of sphingosine 1-phosphate receptor modulators and solid forme thereof11 Aug 2026US 12,703,681 B2Cipla Limited
- Salt form and crystal form of pyrazole substituted imidazo[1,2-a]quinoxaline derivative9 Jun 2026US 12,649,747 B2Ocumension Therapeutics (Suzhou) Co., Ltd.
- Salt of arylaminoquinazoline-containing compound, and preparation method therefor and use thereof26 May 2026US 12,637,434 B2Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Crystalline methionine adenosyltransferase 2a (mat2a) inhibitor and uses thereof24 Sep 2026US 2026/0285830 A1Insilico Medicine IP Limited
- Solid form of pyrrolidone derivative as glucokinase activator24 Sep 2026US 2026/0285835 A1Hua Medicine (Shanghai) Ltd.
- Salt form and crystal form of thienopyrimidine compound, and preparation method therefor and use thereof24 Sep 2026US 2026/0285874 A1Shandong Luye Pharmaceutical Co., Ltd.
- Salt and solid forms of a cdk inhibitor17 Sep 2026US 2026/0274843 A1Genentech, Inc.
- Salts and solid forms of elenestinib17 Sep 2026US 2026/0274850 A1Assia Chemical Industries Ltd.
Most cited
By later US patents
- Polymeric dispersants having alternating polyalkylene and succinic groups111US 5,112,507 AChevron Research and Technology Company · 1992
- Crystalline forms of a purine derivative99US 8,889,861 B2Cyclacel Limited · 2014
- .alpha., .omega.-dicarboxylic acids and medicaments which contain these compounds96US 4,711,896 AEpis S.A. · 1987
- Protein farnesyl transferase inhibitors90US 5,523,430 ABristol-Myers Squibb Company · 1996
- Toll like receptor modulator compounds60US 9,670,205 B2Gilead Sciences, Inc. · 2017